While NOD2 mutations are linked to Crohn's disease occurrence, the exact mechanism by which loss of NOD leads to intestinal inflammation is unclear. Here, Prescott et al demonstrate a possible mechanism by which NOD induces an anti-inflammatory microenvironment with CD103+ Dendritic Cells, possibly opening a avenue for Crohn’s disease therapy.